These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 28193283

  • 1. Circulatory microRNA 23a and microRNA 23b and polycystic ovary syndrome (PCOS): the effects of body mass index and sex hormones in an Eastern Han Chinese population.
    Xiong W, Lin Y, Xu L, Tamadon A, Zou S, Tian F, Shao R, Li X, Feng Y.
    J Ovarian Res; 2017 Feb 13; 10(1):10. PubMed ID: 28193283
    [Abstract] [Full Text] [Related]

  • 2. Non-targeted profiling of circulating microRNAs in women with polycystic ovary syndrome (PCOS): effects of obesity and sex hormones.
    Murri M, Insenser M, Fernández-Durán E, San-Millán JL, Luque-Ramírez M, Escobar-Morreale HF.
    Metabolism; 2018 Sep 13; 86():49-60. PubMed ID: 29410349
    [Abstract] [Full Text] [Related]

  • 3. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J, Bergh T, Gennarelli G, Wide L.
    Clin Endocrinol (Oxf); 1994 Oct 13; 41(4):473-81. PubMed ID: 7955458
    [Abstract] [Full Text] [Related]

  • 4. Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression.
    Murri M, Insenser M, Fernández-Durán E, San-Millán JL, Escobar-Morreale HF.
    J Clin Endocrinol Metab; 2013 Nov 13; 98(11):E1835-44. PubMed ID: 24037889
    [Abstract] [Full Text] [Related]

  • 5. Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome.
    Jiang L, Huang J, Chen Y, Yang Y, Li R, Li Y, Chen X, Yang D.
    Endocrine; 2016 Jul 13; 53(1):280-90. PubMed ID: 26860517
    [Abstract] [Full Text] [Related]

  • 6. Anomalous expression of miR-103 in polycystic ovary syndrome influenced by hormonal, and metabolic variables.
    Mu J, Li Q.
    Exp Mol Pathol; 2020 Oct 13; 116():104482. PubMed ID: 32504622
    [Abstract] [Full Text] [Related]

  • 7. Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective Study.
    Butler AE, Ramachandran V, Cunningham TK, David R, Gooderham NJ, Benurwar M, Dargham SR, Hayat S, Sathyapalan T, Najafi-Shoushtari SH, Atkin SL.
    Front Endocrinol (Lausanne); 2020 Oct 13; 11():571357. PubMed ID: 33101204
    [Abstract] [Full Text] [Related]

  • 8. Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility.
    Tsai YH, Wang TW, Wei HJ, Hsu CY, Ho HJ, Chen WH, Young R, Liaw CM, Chao JC.
    Br J Nutr; 2013 Jun 28; 109(12):2190-8. PubMed ID: 23046530
    [Abstract] [Full Text] [Related]

  • 9. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS.
    J Clin Endocrinol Metab; 1996 Aug 28; 81(8):2854-64. PubMed ID: 8768842
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of circulating microRNA profiles in Brazilian women with polycystic ovary syndrome: A preliminary study.
    De Nardo Maffazioli G, Baracat EC, Soares JM, Carvalho KC, Maciel GAR.
    PLoS One; 2022 Aug 28; 17(10):e0275031. PubMed ID: 36206272
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis.
    Sathyapalan T, David R, Gooderham NJ, Atkin SL.
    Sci Rep; 2015 Nov 19; 5():16890. PubMed ID: 26582398
    [Abstract] [Full Text] [Related]

  • 12. Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome.
    Brennan E, Butler AE, Drage DS, Sathyapalan T, Atkin SL.
    Front Endocrinol (Lausanne); 2023 Nov 19; 14():1233484. PubMed ID: 37790603
    [Abstract] [Full Text] [Related]

  • 13. Identification of miR-16-5p and miR-155-5p microRNAs differentially expressed in circulating leukocytes of pregnant women with polycystic ovary syndrome and gestational diabetes.
    Hocaoglu M, Demirer S, Loclar Karaalp I, Kaynak E, Attar E, Turgut A, Karateke A, Komurcu-Bayrak E.
    Gynecol Endocrinol; 2021 Mar 19; 37(3):216-220. PubMed ID: 33148068
    [Abstract] [Full Text] [Related]

  • 14. Association between Biomarkers of Low-grade Inflammation and Sex Hormones in Women with Polycystic Ovary Syndrome.
    Hatziagelaki E, Pergialiotis V, Kannenberg JM, Trakakis E, Tsiavou A, Markgraf DF, Carstensen-Kirberg M, Pacini G, Roden M, Dimitriadis G, Herder C.
    Exp Clin Endocrinol Diabetes; 2020 Nov 19; 128(11):723-730. PubMed ID: 31461765
    [Abstract] [Full Text] [Related]

  • 15. Validation of circulating microRNAs miR-142-3p and miR-598-3p in women with polycystic ovary syndrome as potential diagnostic markers.
    Insenser M, Quintero A, de Lope S, Álvarez-Blasco F, Martínez-García MÁ, Luque-Ramírez M, Escobar-Morreale HF.
    Hum Reprod; 2023 May 02; 38(5):951-960. PubMed ID: 36931262
    [Abstract] [Full Text] [Related]

  • 16. Relationship between steroid hormones and metabolic profile in women with polycystic ovary syndrome.
    Lazúrová I, Lazúrová Z, Figurová J, Ujházi S, Dravecká I, Mašlanková J, Mareková M.
    Physiol Res; 2019 Jun 30; 68(3):457-465. PubMed ID: 30904012
    [Abstract] [Full Text] [Related]

  • 17. Circulating miRNAs in Women with Polycystic Ovary Syndrome: A Longitudinal Cohort Study.
    Udesen PB, Sørensen AE, Svendsen R, Frisk NLS, Hess AL, Aziz M, Wissing MLM, Englund ALM, Dalgaard LT.
    Cells; 2023 Mar 23; 12(7):. PubMed ID: 37048055
    [Abstract] [Full Text] [Related]

  • 18. Expression of microRNA in follicular fluid in women with and without PCOS.
    Butler AE, Ramachandran V, Hayat S, Dargham SR, Cunningham TK, Benurwar M, Sathyapalan T, Najafi-Shoushtari SH, Atkin SL.
    Sci Rep; 2019 Nov 08; 9(1):16306. PubMed ID: 31705013
    [Abstract] [Full Text] [Related]

  • 19. [Plasma renin and aldosterone levels in obese and non-obese women with polycystic ovary syndrome].
    Mejia-Montilla J, Reyna-Villasmil E, Torres-Cepeda D, Santos-Bolívar J, Reyna-Villasmil N, Bravo-Henríquez A.
    Endocrinol Nutr; 2012 Jan 08; 59(1):21-7. PubMed ID: 22115703
    [Abstract] [Full Text] [Related]

  • 20. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X, Lin JF.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 07; 85(46):3266-71. PubMed ID: 16409817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.